Otosclerosis: An autoimmune disease?

Autoimmunity Reviews

Volumn 9, Issue 2, 2009, Pages 95-101

  Karosi, Tamás ^a   Szekanecz, Zoltán ^a   Sziklai, István ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Autoimmunity; Epidemiology; Etiopathogenesis; Genetics; Inflammation; Measles virus; Otosclerosis

Indexed keywords

AUTOIMMUNE DISEASE; BONE METABOLISM; BONE REMODELING; CLINICAL FEATURE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; OSTEOLYSIS; OTOSCLEROSIS; PATHOGENESIS; PROSPECTIVE STUDY; REVIEW; STAPES; VIRUS INFECTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; COLLAGEN TYPE I; COMORBIDITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEASLES; MEASLES VIRUS; OTOSCLEROSIS; POLYMORPHISM, GENETIC; VITAMIN D;

EID: 70350564881     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.03.009     Document Type: Review

References (41)

1. Iyer P.V., and Gristwood R.E. Histopathology of the stapes in otosclerosis. Pathology 16 (1984) 30-38
2. Linthicum Jr. F.H. Histopathology of otosclerosis. Otolaryngol Clin North Am 26 (1993) 335-352
3. Gros A., Vatovec J., and Sereg-Bahar M. Histologic changes on stapedial footplate in otosclerosis. Correlations between histologic activity and clinical findings. Otol Neurotol 24 (2003) 43-47
4. Karosi T., Kónya J., Petkó M., Szabó L.Z., Pytel J., Jóri J., et al. Two subgroups of stapes fixation: otosclerosis and pseudo-otosclerosis. Laryngoscope 115 (2005) 1968-1973
5. Karosi T., Kónya J., Petkó M., and Sziklai I. Histologic otosclerosis is associated with the presence of measles virus in the stapes footplate. Otol Neurotol 26 (2005) 1128-1133
6. Stankovic K.M., and McKenna M.J. Current research in otosclerosis. Curr Opin Otolaryngol Head Neck Surg 14 (2006) 347-351
7. Niedermeyer H.P., Becker E.T., and Arnold W. Expression of collagens in the otosclerotic bone. Adv Otorhinolaryngol 65 (2007) 45-49
8. Arnold W., and Friedmann I. Immunohistochemistry of otosclerosis. Acta Otolaryngol Suppl 470 (1990) 124-128
9. Karosi T., Jókay I., Kónya J., Petkó M., Szabó L.Z., and Sziklai I. Expression of measles virus receptors in otosclerotic, non-otosclerotic and in normal stapes footplates. Eur Arch Otorhinolaryngol 264 (2007) 607-613
10. Karosi T., Jókay I., Kónya J., Petkó M., Szabó L.Z., Pytel J., et al. Activated osteoclasts with CD51/61 expression in otosclerosis. Laryngoscope 116 (2006) 1478-1484
11. Szekanecz Z., Szekanecz E., Morvai K., Rácz T., Szegedi G., and Sziklai I. Current aspects of the pathogenesis and clinical characteristics of otosclerosis: possibilities of drug therapy. Hung Med J (Orv Hetil) 140 (1999) 2435-2440
12. Dahlqvist A., Diamant H., Dahlqvist S.R., and Cedergren B. HLA antigens in patients with otosclerosis. Acta Otolaryngol 100 (1985) 33-35
13. Bernstein J.M., Shanahan T.C., and Schaffer F.M. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol 116 (1996) 666-671
14. McKenna M.J., Kristiansen A.G., Bartley M.L., Rogus J.J., and Haines J.L. Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta. Am J Otol 19 (1998) 604-610
15. McKenna M.J., Kristiansen A.G., and Tropitzsch A.S. Similar COL1A1 expression in fibroblasts from some patients with clinical otosclerosis and those with type I osteogenesis imperfecta. Ann Otol Rhinol Laryngol 111 (2002) 184-189
16. Rodríguez L., Rodríguez S., Hermida J., Frade C., Sande E., Visedo G., et al. Proposed association between the COL1A1 and COL1A2 genes and otosclerosis is not supported by a case-control study in Spain. Am J Med Genet A 128A (2004) 19-22
17. Chen W., Meyer N.C., McKenna M.J., Pfister M., McBride Jr. D.J., Fukushima K., et al. Single-nucleotide polymorphisms in the COL1A1 regulatory regions are associated with otosclerosis. Clin Genet 71 (2007) 406-414
18. Van Den Bogaert K., Govaerts P.J., De Leenheer E.M., Schatteman I., Verstreken M., Chen W., et al. Otosclerosis: a genetically heterogeneous disease involving at least three different genes. Bone 30 (2002) 624-630
19. Norrby E., and Oxman M.N. Measles virus. In: Fields B.N., and Knipe D.M. (Eds). Fields Virology (1990), Raven Press, New York 1013-1044
20. Arnold W., and Friedmann I. Otosclerosis-an inflammatory disease of the otic capsule of viral aetiology?. J Laryngol Otol 102 (1988) 865-871
21. Arnold W., Niedermeyer H.P., Lehn N., Neubert W., and Höfler H. Measles virus in otosclerosis and the specific immune response of the inner ear. Acta Otolaryngol 116 (1996) 705-709
22. Niedermeyer H.P., and Arnold W. Otosclerosis: a measles virus associated inflammatory disease. Acta Otolaryngol 115 (1995) 300-303
23. Karosi T., Kónya J., Petkó M., Szabó L.Z., Pytel J., Jóri J., et al. Antimeasles immunoglobulin g for serologic diagnosis of otosclerotic hearing loss. Laryngoscope 116 (2006) 488-493
24. Karosi T., Kónya J., Szabó L.Z., and Sziklai I. Measles virus prevalence in otosclerotic stapes footplate samples. Otol Neurotol 25 (2004) 451-456
25. Karosi T., Szalmás A., Csomor P., Kónya J., Petkó M., and Sziklai I. Disease-associated novel CD46 splicing variants and pathologic bone remodeling in otosclerosis. Laryngoscope 118 (2008) 1669-1676
26. Yoo T.J. Etiopathogenesis of otosclerosis: a hypothesis. Ann Otol Rhinol Laryngol 93 (1984) 28-33
27. Joliat T., Seyer J., Bernstein J., Krug M., Ye X.J., Cho J.S., et al. Antibodies against a 30 kDa cochlear protein and type II and IX collagens in the serum of patients with inner ear diseases. Ann Otol Rhinol Laryngol 101 (1992) 1000-1006
28. Yoo T.J., Shea Jr. J.J., and Floyd R.A. Enchondral cartilage rests collagen-induced autoimmunity: a possible pathogenetic mechanism of otosclerosis. Am J Otolaryngol 8 (1987) 317-324
29. Thys M., Schrauwen I., Vanderstraeten K., Janssens K., Dieltjens N., Van Den Bogaert K., et al. The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations. Hum Mol Genet 16 (2007) 2021-2030
30. Thys M., Schrauwen I., Vanderstraeten K., Dieltjens N., Fransen E., Ealy M., et al. Detection of rare nonsynonymous variants in TGFB1 in otosclerosis patients. Ann Hum Genet (Jan 30 2009) [Electronic publication ahead of print]
31. Karosi T., Jókay I., Kónya J., Szabó L.Z., Pytel J., Jóri J., et al. Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity. Laryngoscope 116 (2006) 1427-1433
32. Karosi T., Kónya J., Szabó L.Z., Pytel J., Jóri J., Szalmás A., et al. Codetection of measles virus and tumor necrosis factor-alpha mRNA in otosclerotic stapes footplates. Laryngoscope 115 (2005) 1291-1297
33. Zehnder A.F., Kristiansen A.G., Adams J.C., Kujawa S.G., Merchant S.N., and McKenna M.J. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss. Laryngoscope 116 (2006) 201-206
34. Lehnerdt G., Metz K.A., Trellakis S., Jahnke K., and Neumann A. Signaling by way of type IB and II bone morphogenetic protein receptors regulates bone formation in otospongiosis. Laryngoscope 117 (2007) 812-816 Erratum in:
35. Lehnerdt G., Metz K.A., Trellakis S., Jahnke K., and Neumann A. Signaling by way of type IB and II bone morphogenetic protein receptors regulates bone formation in otospongiosis. Laryngoscope 117 (2007) 1510
36. Imauchi Y., Jeunemaître X., Boussion M., Ferrary E., Sterkers O., and Grayeli A.B. Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study. Otol Neurotol 29 (2008) 295-301
37. Horner K.C. The effect of sex hormones on bone metabolism of the otic capsule-an overview. Hear Res (Dec 24 2008) [Electronic publication ahead of print]
38. Huang C.C., Yabe Y., and Yan S.D. Effects of indomethacin and calcitonin on bone absorption in type II collagen-induced otossclerosis-like lesions in rats. Otolaryngol Head Neck Surg 103 (1990) 1002-1008
39. Van Wijk F., Staecker H., Keithley E., and Lefebvre P.P. Local perfusion of the tumor necrosis factor alpha blocker infliximab to inner ear improves autoimmune neurosensory hearing loss. Audiol Neuro-otol 11 (2006) 357-365
40. Brookler K. Medical treatment of otosclerosis: rationale for use of bisphosphonates. Int Tinnitus J 14 (2008) 92-96
41. Brookes G.B. Vitamin D deficiency and otosclerosis. Otolaryngol Head Neck Surg 93 (1985) 313-321